Transcriptomic responses of peripheral blood mononuclear cells to cyclosporin and etanercept in a female infant with juvenile generalized pustular psoriasis
Experimental Dermatology · 2023
DOI: 10.1111/exd.14835 ↗Kurz gefasst
Fachartikel in der Zeitschrift Experimental Dermatology, 2023. Verfasst von Yu-Chen Lin und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan. Hauptthemen laut MEDLINE: Cyclosporine, Psoriasis. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 27 Literaturangaben.
Abstract (Originalsprache)
Generalized pustular psoriasis (GPP) is a rare but severe form of psoriasis. An early onset of the diseases is correlated with mutations among IL36RN , CARD14 , AP1S3 , MPO and SERPINA3 genes. Systemic biological agents including anti‐TNF‐α, anti‐IL‐17, anti‐IL‐12/IL‐23, anti‐IL1R, anti‐IL1β and anti‐IL‐36R act as novel treatment methods for GPP. Herein we report a female infant clinically diagnosed with GPP since she was 10‐month‐old. Results of whole‐exome sequencing (WES) and Sanger sequencing revealed a reported heterozygous IL36RN (c.115+6T>C) and another reported heterozygous SERPINA3 frame‐shifting variant (c.1247_1248del). Initial cyclosporin treatment for the patient led to a partial remission of the symptoms. However, the patient reached nearly total remission of pustules and erythema after anti‐TNF‐α inhibitor etanercept treatment. Results of further RNA sequencing (RNA‐seq) done on peripheral blood mononuclear cells correlated with the clinical responses, showing that cyclosporin suppressed a portion of the neutrophil‐related genes, while most genes associated with neutrophil activation, neutrophil‐mediated immunity and degranulation were downregulated by the subsequent etanercept treatment. We report this case to demonstrate WES and RNA‐seq in combination could come in handy in reaching a precise diagnosis and in evaluating or even predicting the molecular alterations underlying clinical treatment effectiveness.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
- International Center for Wound Repair and Regeneration (iWRR), National Cheng Kung University, Tainan, Taiwan.
- Institute of Clinical Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
- School of Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
ORCID-Profile: Yu-Chen Lin, Yu-Chen Jeng, Yi-Kai Hong, Chao-Chun Yang, Chao-Kai Hsu
Zitieren
APA
Lin, Y. C., Jeng, Y. C., Aala, W. J. F., Hong, Y. K., Chen, P. H., Chuang, Y. R., Yang, C. C., & Hsu, C. K. (2023). Transcriptomic responses of peripheral blood mononuclear cells to cyclosporin and etanercept in a female infant with juvenile generalized pustular psoriasis. Experimental Dermatology. https://doi.org/10.1111/exd.14835
Vancouver
Lin YC, Jeng YC, Aala WJF, Hong YK, Chen PH, Chuang YR, et al. Transcriptomic responses of peripheral blood mononuclear cells to cyclosporin and etanercept in a female infant with juvenile generalized pustular psoriasis. Experimental Dermatology. 2023. doi:10.1111/exd.14835
BibTeX
@article{Lin2023,
author = {Lin, Yu-Chen and Jeng, Yu-Chen and Aala, Wilson Jr F and Hong, Yi-Kai and Chen, Pin-Hsuan and Chuang, Ya-Ru and Yang, Chao-Chun and Hsu, Chao-Kai},
title = {Transcriptomic responses of peripheral blood mononuclear cells to cyclosporin and etanercept in a female infant with juvenile generalized pustular psoriasis},
journal = {Experimental Dermatology},
year = {2023},
doi = {10.1111/exd.14835}
}
EUVIMED